Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buspirone as an Adjunctive Medication for Opioid Tapering

NCT03521960 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03521960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03521960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buspirone as an Adjunctive Medication for Opioid Tapering
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
May 30, 2018
Completion date
June 30, 2020
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dependency (psychology), opiate withdrawal syndrome, opioid-related disorders, pain, chronic